Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Profit After Tax: 2010-2024

Historic Profit After Tax for Whitehawk Therapeutics (WHWK) over the last 13 years, with Dec 2024 value amounting to -$63.7 million.

  • Whitehawk Therapeutics' Profit After Tax fell 41.45% to -$17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.6 million, marking a year-over-year increase of 74.67%. This contributed to the annual value of -$63.7 million for FY2024, which is 3.14% up from last year.
  • Per Whitehawk Therapeutics' latest filing, its Profit After Tax stood at -$63.7 million for FY2024, which was up 3.14% from -$65.8 million recorded in FY2023.
  • Over the past 5 years, Whitehawk Therapeutics' Profit After Tax peaked at -$3.5 million during FY2020, and registered a low of -$110.1 million during FY2021.
  • Moreover, its 3-year median value for Profit After Tax was -$63.7 million (2024), whereas its average is -$63.3 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first spiked by 84.96% in 2020, then crashed by 3,045.71% in 2021.
  • Over the past 5 years, Whitehawk Therapeutics' Profit After Tax (Yearly) stood at -$3.5 million in 2020, then crashed by 3,045.71% to -$110.1 million in 2021, then spiked by 45.04% to -$60.5 million in 2022, then fell by 8.68% to -$65.8 million in 2023, then rose by 3.14% to -$63.7 million in 2024.